Condition:   Early Rheumatoid Arthritis
Interventions:   Biological: Adalimumab;   Drug: Methotrexate;   Biological: Adalimumab placebo;   Drug: Methotrexate placebo
Sponsor:   Abbott
Active, not recruiting - verified May 2011